第一个完全在加拿大制造的新冠疫苗 已在多伦多开始了人体试验。 疫苗背后的这家卡尔加里公司Providence Therapeutics说其准备在卡尔加里建立一个生产设施来生产其新冠疫苗, 并将为加拿大提供可靠的新冠疫苗供应。
–
Providence Therapeutics announced Tuesday that it has begun dosing volunteers in human clinical trials of its COVID-19 vaccine, the first fully made-in Canada COVID vaccine to reach this stage of development. OMNI Mandarin spoke with CEO Brad Sorenson to get a better understanding of it’s place in the market and Dr. Matthew Oughton for some perspective on this new PTX-COVID19-B messenger RNA (mRNA) vaccine.
Providence Therapeutics begins human trials of Canadian COVID-19 vaccine
